| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |